DRUG

EMO

3 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for EMO

Epilepsy 2

Mediator Outcome Score Tier Lit. status Trial
HMGB1 epilepsy 0.248 Mid partial evidence none
HMGB1 drug-resistant epilepsy 0.208 Mid novel signal none

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid partial evidence none

Clinical trials

9 registered trials for EMO

Source: ClinicalTrials.gov